C. Hal Jones

2.1k total citations
44 papers, 1.6k citations indexed

About

C. Hal Jones is a scholar working on Molecular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, C. Hal Jones has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Medicine, 18 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in C. Hal Jones's work include Antibiotic Resistance in Bacteria (21 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Microbial Natural Products and Biosynthesis (8 papers). C. Hal Jones is often cited by papers focused on Antibiotic Resistance in Bacteria (21 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Microbial Natural Products and Biosynthesis (8 papers). C. Hal Jones collaborates with scholars based in United Kingdom, United States and Australia. C. Hal Jones's co-authors include Patricia A. Bradford, Peter J. Petersen, Alain Filloux, Margareta Tuckman, Abderrahman Hachani, Sophie Bleves, Eshwar Mahenthiralingam, Julian Parkhill, Alexey Ruzin and Nadine Lossi and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

C. Hal Jones

43 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Hal Jones United Kingdom	23	673	494	387	381	254	44	1.6k
Jesús Aranda Spain	22	1.0k 1.5×	601 1.2×	492 1.3×	211 0.6×	108 0.4×	31	1.6k
Zhihui Zhou China	19	1.1k 1.6×	580 1.2×	466 1.2×	226 0.6×	129 0.5×	51	1.5k
Jesús Silva-Sánchez Mexico	26	1.3k 1.9×	600 1.2×	583 1.5×	229 0.6×	99 0.4×	83	1.8k
Alicia Fajardo Lubián Australia	13	850 1.3×	767 1.6×	231 0.6×	180 0.5×	141 0.6×	22	1.8k
Hidetada Hirakawa Japan	22	665 1.0×	877 1.8×	459 1.2×	120 0.3×	264 1.0×	54	1.8k
N Claire Gordon United Kingdom	20	1.1k 1.6×	772 1.6×	363 0.9×	350 0.9×	97 0.4×	37	2.1k
Jerónimo Rodríguez-Beltrán Spain	20	853 1.3×	690 1.4×	256 0.7×	172 0.5×	93 0.4×	40	1.7k
Margarita Poza Spain	30	1.2k 1.8×	1.2k 2.4×	654 1.7×	217 0.6×	219 0.9×	71	2.4k
Ulises Garza–Ramos Mexico	24	1.5k 2.2×	562 1.1×	659 1.7×	213 0.6×	123 0.5×	68	1.8k
Chew Chieng Yeo Malaysia	26	733 1.1×	787 1.6×	462 1.2×	104 0.3×	138 0.5×	88	1.7k

Countries citing papers authored by C. Hal Jones

Since Specialization

Citations

This map shows the geographic impact of C. Hal Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Hal Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Hal Jones more than expected).

Fields of papers citing papers by C. Hal Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Hal Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Hal Jones. The network helps show where C. Hal Jones may publish in the future.

Co-authorship network of co-authors of C. Hal Jones

This figure shows the co-authorship network connecting the top 25 collaborators of C. Hal Jones. A scholar is included among the top collaborators of C. Hal Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Hal Jones. C. Hal Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Yubing, Rassim Khelifa, Amina Ali, et al.. (2025). Diagnostic technologies for neuroblastoma. Lab on a Chip. 25(15). 3630–3664. 1 indexed citations

Jones, C. Hal, Gordon Webster, Alex J. Mullins, et al.. (2021). Kill and cure: genomic phylogeny and bioactivity of Burkholderia gladioli bacteria capable of pathogenic and beneficial lifestyles. Microbial Genomics. 7(1). 32 indexed citations

Webster, Gordon, C. Hal Jones, Alex J. Mullins, & Eshwar Mahenthiralingam. (2020). A rapid screening method for the detection of specialised metabolites from bacteria: Induction and suppression of metabolites from Burkholderia species. Journal of Microbiological Methods. 178. 106057–106057. 10 indexed citations

Marshall, Helen, James Baber, Peter Richmond, et al.. (2019). S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine. Journal of Infection. 79(6). 582–592. 5 indexed citations

Masschelein, Joleen, Paulina K. Sydor, Christian Hobson, et al.. (2019). A dual transacylation mechanism for polyketide synthase chain release in enacyloxin antibiotic biosynthesis. Nature Chemistry. 11(10). 906–912. 26 indexed citations

Mullins, Alex J., J. A. H. Murray, Matthew Bull, et al.. (2019). Genome mining identifies cepacin as a plant-protective metabolite of the biopesticidal bacterium Burkholderia ambifaria. Nature Microbiology. 4(6). 996–1005. 105 indexed citations

Loveridge, E. Joel, C. Hal Jones, Matthew Bull, et al.. (2017). Reclassification of the Specialized Metabolite Producer Pseudomonas mesoacidophila ATCC 31433 as a Member of the Burkholderia cepacia Complex. Journal of Bacteriology. 199(13). 21 indexed citations

Song, Lijiang, Matthew Jenner, Joleen Masschelein, et al.. (2017). Discovery and Biosynthesis of Gladiolin: A Burkholderia gladioli Antibiotic with Promising Activity against Mycobacterium tuberculosis. Journal of the American Chemical Society. 139(23). 7974–7981. 74 indexed citations

Jenner, Matthew, Joleen Masschelein, Yousef Dashti, et al.. (2016). Biosynthesis of a 'fungal' peptide antibiotic by Burkholderia gladioli. Planta Medica. 81(S 01). S1–S381. 2 indexed citations

10.

Rozemeijer, Wouter, Pamela S. Fink, Eduardo A. Peña Rojas, et al.. (2015). Evaluation of Approaches to Monitor Staphylococcus aureus Virulence Factor Expression during Human Disease. PLoS ONE. 10(2). e0116945–e0116945. 42 indexed citations

11.

Kodali, Srinivas, Evgeny Vinogradov, Fiona L. Lin, et al.. (2015). A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium. Journal of Biological Chemistry. 290(32). 19512–19526. 36 indexed citations

12.

Sana, Thibault G., Christoph Baumann, Andreas Merdes, et al.. (2015). Internalization of Pseudomonas aeruginosa Strain PAO1 into Epithelial Cells Is Promoted by Interaction of a T6SS Effector with the Microtubule Network. mBio. 6(3). e00712–e00712. 137 indexed citations

13.

Petersen, Peter J., Alexey Ruzin, Margareta Tuckman, & C. Hal Jones. (2010). In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for diabetic foot infections. Diagnostic Microbiology and Infectious Disease. 66(4). 407–418. 11 indexed citations

14.

Ruzin, Alexey, Peter J. Petersen, & C. Hal Jones. (2009). Resistance development profiling of piperacillin in combination with the novel -lactamase inhibitor BLI-489. Journal of Antimicrobial Chemotherapy. 65(2). 252–257. 15 indexed citations

15.

Bradford, Patricia A., Peter J. Petersen, Margareta Tuckman, & C. Hal Jones. (2008). In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia. Clinical Microbiology and Infection. 14(9). 882–886. 15 indexed citations

16.

Jones, C. Hal, et al.. (2008). Genetic Determinants of Tetracycline Resistance and their Effect on Tetracycline and Glycylcycline Antibiotics. 7(2). 84–96. 5 indexed citations

17.

Petersen, Peter J., C. Hal Jones, & Patricia A. Bradford. (2007). In vitro antibacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller-Hinton broth. Diagnostic Microbiology and Infectious Disease. 59(3). 347–349. 58 indexed citations

18.

Jones, C. Hal, Margareta Tuckman, Ellen Murphy, & Patricia A. Bradford. (2006). Identification and Sequence of a tet (M) Tetracycline Resistance Determinant Homologue in Clinical Isolates of Escherichia coli. Journal of Bacteriology. 188(20). 7151–7164. 33 indexed citations

19.

Petersen, Peter J., et al.. (2006). In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. Journal of Antimicrobial Chemotherapy. 57(3). 573–576. 227 indexed citations

20.

Jones, C. Hal & Peter J. Petersen. (2005). Tigecycline: A review of preclinical and clinical studies of thefirst-in-class glycylcycline antibiotic. Drugs of today. 41(10). 637–637. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact